ADAM12 Promotes Gemcitabine Resistance by Activating EGFR Signaling Pathway and Induces EMT in Bladder Cancer.
Clinical & translational oncology（2022）
Key words
ADAM12,Gemcitabine resistance,EGFR,EMT,Bladder cancer
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined